| http://www.w3.org/ns/prov#value | - Now, the report included studies of patients with various forms of liver disease, and they found that several types of liver disease may prolong the half-life of the drug, but they could not conclude that this increase would also increase the risk of hepatotoxicity, and they were unable to conclude whether it was safe for use in patients with preexisting liver disease.
|
